The Joint Task Force (JTF) for Clinical Trial Competency Framework will share important feedback from more than 2,500 survey respondents at the ACRP 2016 Meeting & Expo, according to JTF Co-Chair Stephen Sonstein, PhD, director of Clinical Research Administration at Eastern Michigan University in Fort Myers, Fla. "We'll talk about definitions and perceptions of core […]
Clinical researchers who fail to adequately document corrective and preventive action (CAPA) programs are missing out on a number of important benefits to save time and money, says Beth D. Harper, MBA, president of Clinical Performance Partners, Inc. "It's not just a compliance tool," she stresses. Instead, CAPA can be leveraged to dig deeper and […]
Comments submitted regarding Notice of Proposed Rulemaking Federal Policy for the Protection of Human Subjects. (Docket number: HHS-OPHS-2015-0008).
Comments submitted on Using Technologies and Innovative Methods to Conduct FDA-Regulated Clinical Investigations of Investigational Drugs.
Raising public awareness of clinical trials is the focus of many initiatives, yet many of the people who carry out clinical trial operations remain unsung.
